β-amyloid deposition is shifted to the vasculature and memory impairment is exacerbated when hyperhomocysteinemia is induced in APP/PS1 transgenic mice.
about
Pathophysiologic relationship between Alzheimer's disease, cerebrovascular disease, and cardiovascular risk: A review and synthesisTranslational models for vascular cognitive impairment: a review including larger speciesCerebrovascular contributions to aging and Alzheimer's disease in Down syndrome.Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's diseaseVascular Contributions to Cognitive Impairment and Dementia: Topical Review of Animal Models.Reduced Efficacy of Anti-Aβ Immunotherapy in a Mouse Model of Amyloid Deposition and Vascular Cognitive Impairment Comorbidity.Development of an in-vivo active reversible butyrylcholinesterase inhibitor.Cerebral amyloid angiopathy, subcortical white matter disease and dementia: literature review and study in OPTIMA.Potential mechanisms and implications for the formation of tau oligomeric strains.Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease.Hyperhomocysteinemia-Induced Gene Expression Changes in the Cell Types of the Brain.An emerging role of astrocytes in vascular contributions to cognitive impairment and dementia.Time-course of glial changes in the hyperhomocysteinemia model of vascular cognitive impairment and dementia (VCID).Rodent Models of Cerebral Microinfarct and Microhemorrhage.The Physiological Roles of Amyloid-β Peptide Hint at New Ways to Treat Alzheimer's Disease.
P2860
Q30235369-6A23D524-A9AD-4C51-9C58-CCDBF4A2F46BQ36259074-C3838B70-8927-43E3-ABDD-DC15932A2B5DQ36767734-1EDEB50F-9D25-45E7-9607-791524B28F3CQ36767796-76FC8F93-5D9E-4578-9124-9EF818AA8E10Q37052971-EF556AC0-D18D-48E6-84D9-404BDC3EB8A1Q37270930-174C4D2B-3863-4152-B1F0-ECD9933674D0Q37522451-EAF47FB1-29DF-4521-B770-EA7086F5AD41Q38292899-4B64FE1B-6EF6-4F5D-BA1F-42BA2767EF1FQ38960046-E297B607-0DE5-4F58-8D33-FF9E8ECC3FFDQ39313671-DF08628B-048C-4E54-975B-F18210E6F343Q47110397-8CED2B26-B985-4773-ACFE-E395A106FF80Q47924927-A4E11C04-5677-433A-AF08-77FF8CB6070FQ48415424-FD03141F-E67F-4DB3-8463-E42CCA8087ECQ49832870-B7982B50-70E4-44B0-B286-EC6C0CFC1B58Q55411317-6BDE9A1D-5503-4FFE-96FC-86B6873E81A1
P2860
β-amyloid deposition is shifted to the vasculature and memory impairment is exacerbated when hyperhomocysteinemia is induced in APP/PS1 transgenic mice.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
β-amyloid deposition is shifte ...... ed in APP/PS1 transgenic mice.
@ast
β-amyloid deposition is shifte ...... ed in APP/PS1 transgenic mice.
@en
type
label
β-amyloid deposition is shifte ...... ed in APP/PS1 transgenic mice.
@ast
β-amyloid deposition is shifte ...... ed in APP/PS1 transgenic mice.
@en
prefLabel
β-amyloid deposition is shifte ...... ed in APP/PS1 transgenic mice.
@ast
β-amyloid deposition is shifte ...... ed in APP/PS1 transgenic mice.
@en
P2093
P2860
P356
P1476
β-amyloid deposition is shifte ...... ed in APP/PS1 transgenic mice.
@en
P2093
Donna M Wilcock
Erica M Weekman
Holly M Brothers
Kaitlyn Braun
Tiffany L Sudduth
P2860
P2888
P356
10.1186/ALZRT262
P407
P577
2014-06-09T00:00:00Z
P5875
P6179
1023755343